Pathogenetic treatment of influenza patients with aerosolized form of aprotinin, a protease inhibitor

Therapeutic and antiviral efficacies of inhalations of aerosolized aprotinin, a protease inhibitor, which blocks a stage of influenza virus proteolytic activation, were studied. This clinical study was performed during winter-spring outbreak caused with pandemic Influenza H1N1pdm09. Aprotinin (a nat...

Descripción completa

Detalles Bibliográficos

Autores principales:	O. P. Zhirnov, N. O. Bokova, E. I. Isaeva, I. V. Vorobieva, N. A. Malyshev
Formato:	Artigo
Lenguaje:	Russo
Publicado:	Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-02-01
Colección:	Биопрепараты: Профилактика, диагностика, лечение
Materias:	influenza pathogenesis aprotinin chemotherapeutic compound therapy proteolytic activation грипп патогенез апротинин химиопрепарат лечение протеолитическая активация
Acceso en línea:	https://www.biopreparations.ru/jour/article/view/35
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!